HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,008 | -83.6% | 52,558 | -84.5% | 0.02% | -81.0% |
| Q2 2023 | $12,262 | +108.7% | 339,963 | +121.0% | 0.10% | +104.1% |
| Q1 2023 | $5,876 | +6.2% | 153,852 | +58.2% | 0.05% | -38.8% |
| Q4 2022 | $5,533 | -99.9% | 97,248 | -1.8% | 0.08% | +56.9% |
| Q3 2022 | $3,914,000 | -44.5% | 98,983 | -38.2% | 0.05% | -40.7% |
| Q2 2022 | $7,052,000 | +38.3% | 160,279 | +25.3% | 0.09% | +34.4% |
| Q1 2022 | $5,099,000 | +129.6% | 127,868 | +131.5% | 0.06% | +178.3% |
| Q4 2021 | $2,221,000 | +65.6% | 55,232 | +71.7% | 0.02% | +15.0% |
| Q1 2021 | $1,341,000 | -1.1% | 32,161 | -37.7% | 0.02% | -25.9% |
| Q3 2020 | $1,356,000 | +4.1% | 51,617 | +6.3% | 0.03% | -20.6% |
| Q2 2020 | $1,302,000 | +171.8% | 48,563 | +79.7% | 0.03% | +277.8% |
| Q4 2019 | $479,000 | – | 27,032 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |